Roche’s live audio webcast and conference call from ESMO IO 2017

Please register to access the replay*

*Privacy notice

IMpower150: Phase 3 results of carboplatin + paclitaxel +/- Avastin, with or without Tecentriq in 1L non-squamous metastatic NSCLC
Tecentriq program overview: Focusing on novel combination approaches
Alan Sandler, M.D., Global Development Team Leader Tecentriq Lung
Cathi Ahearn, Global Product Strategy Tecentriq
Past IR Events
View more Events


Related links